Levin 400 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Levin 400 mg Tablet contains imatinib mesylate, a tyrosine kinase inhibitor. Its labelling describes it for the treatment of blood cancers (chronic myeloid leukemia and acute lymphoblastic leukemia), gastrointestinal stromal tumours, myelodysplastic disease, dermatofibrosarcoma protuberans, and aggressive systemic mastocytosis. It is described as targeting certain proteins that trigger the growth and spread of cancer cells. Results can take several weeks or months, and the doctor regularly monitors liver function and blood cells.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Chronic myeloid leukemia (CML) — a blood cancer affecting white blood cells
- Acute lymphoblastic leukemia (ALL) — affecting the blood and bone marrow
- Gastrointestinal stromal tumours (GIST) — affecting the digestive tract
- Myelodysplastic disease and dermatofibrosarcoma protuberans (DFSP); also aggressive systemic mastocytosis
Described Dosage & Administration
- Prescribed by a healthcare professional according to condition, symptoms, or lab tests; not to be self-administered
- Consumed regularly as directed; it should not be stopped or overdosed, as this can lead to serious side effects
- Long-term results can take weeks or months; liver function and blood cells are monitored during treatment
Described Side Effects
Commonly described side effects include:
- Edema (swelling)
- Nausea and vomiting
- Muscle cramps
- Diarrhoea
- Rash
- Fatigue
- Abdominal pain
These normally reduce after some time. Any unexplained weight gain should be reported to the doctor.
Precautions
- It can interact with other medicines; the doctor should be informed, especially about medicines for kidney or liver problems
- Alcohol should not be consumed during the course
- Expectant women and lactating mothers should consult the doctor before use, and both men and women should use contraception during treatment
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains imatinib mesylate and is used for chronic myeloid leukemia, acute lymphoblastic leukemia, GIST, and other conditions. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as prescribed by a healthcare professional according to condition and lab tests, consumed regularly as directed, and not stopped or overdosed; it is not for self-administration.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.